Pharma & Biotech

Investors in Hims & Hers Health have endured a turbulent period, with recent volatility testing shareholder resolve. Following weeks of...

Redcare Pharmacy shares may be finding a tentative foothold after enduring significant market pressure. The online pharmacy company concluded Friday's...

Investors in Novo Nordisk experienced significant volatility this past week, buffeted by contrasting developments across clinical trials and regulatory landscapes....

The biotechnology firm Akari Therapeutics finds itself navigating a critical period as it confronts the dual challenge of potential stock...

Keros Therapeutics (KROS) finds itself at the center of conflicting market narratives this Friday, presenting investors with a complex puzzle....

After a remarkable performance this year, Assembly Biosciences appears well-positioned for its next growth phase. Distinguished from many cash-strapped competitors...

Following a disastrous performance this year that saw its value nearly halve since January, Redcare Pharmacy investors are searching for...

A substantial purchase by a major shareholder has propelled Standard BioTools stock significantly higher. Casdin Capital, the company's largest investor,...

The Danish pharmaceutical giant Novo Nordisk is navigating a challenging period that would have seemed improbable just two years ago....

Time is running out for investors in CureVac as the company's independence draws to a close. The German biopharmaceutical firm,...